Hoya, Japan

Ichiro Isaka


Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 58(Granted Patents)


Location History:

  • Hoys, JA (1977)
  • Hoya, JA (1976 - 1978)
  • Hoya, JP (1982)

Company Filing History:


Years Active: 1976-1982

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Ichiro Isaka: Innovator in Cephalosporin Compounds

Introduction

Ichiro Isaka is a prominent inventor based in Hoya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 8 patents to his name, Isaka's work has had a substantial impact on antimicrobial treatments.

Latest Patents

Isaka's latest patents focus on cephalosporin compounds characterized by a general formula that includes various functional groups. These compounds exhibit excellent antimicrobial activity against a range of microorganisms, including resistant bacteria. They are particularly useful in treating bacterial infections in both animals and humans. One notable patent describes a novel cephalosporin derivative featuring a heterocyclic thiomethyl group and an acylaminophenylacetamide group, which demonstrates strong antibacterial activity against Pseudomonas and Proteus strains.

Career Highlights

Ichiro Isaka has dedicated his career to advancing pharmaceutical innovations. He is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in research and development efforts. His work has not only contributed to the scientific community but has also improved treatment options for bacterial infections.

Collaborations

Isaka has collaborated with notable colleagues, including Masuo Murakami and Akio Koda. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical compounds.

Conclusion

Ichiro Isaka's contributions to the field of cephalosporin compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in antimicrobial treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…